Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Ferdinandy

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Basic Research in Cardiology|June 27, 2024
Sodium-glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyondMassimiliano Camilli, Marcello Viscovo, Luca Maggio, et al.
Cardiovascular Research|January 22, 2013
Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of CardiologyDerek J Hausenloy, Hans Erik Bøtker, Gianluigi Condorelli, et al.
International Journal of Cardiology|May 15, 2015
Cardioprotection by gene therapy: A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of CardiologyRosalinda Madonna, Christian Cadeddu, Martino Deidda, et al.
Scientific Reports|May 18, 2018
JDP2 overexpression provokes cardiac dysfunction in miceJacqueline Heger, Julia Bornbaum, Alona Würfel, et al.
Cardiovascular Research|October 26, 2014
ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapiesSandrine Lecour, Hans E Bøtker, Gianluigi Condorelli, et al.
Cardiovascular Research|June 12, 2021
COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the HeartMaurizio Pesce, Piergiuseppe Agostoni, Hans-Erik Bøtker, et al.
Redox Biology|October 15, 2023
Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotectionGerd Heusch, Ioanna Andreadou, Robert Bell, et al.
Basic Research in Cardiology|October 18, 2024
The IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): multicenter pig study on the effect of ischemic preconditioningPetra Kleinbongard, Carlos Galán Arriola, Lina Badimon, et al.
Cardiovascular Research|January 19, 2019
ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failureRosalinda Madonna, Linda W Van Laake, Hans Erik Botker, et al.
Cardiovascular Research|September 10, 2021
Circadian rhythms in ischaemic heart disease: key aspects for preclinical and translational research: position paper of the ESC working group on cellular biology of the heartSandrine Lecour, Bastiaan C Du Pré, Hans Erik Bøtker, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Basic Research in Cardiology|June 27, 2024
Sodium-glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyondMassimiliano Camilli, Marcello Viscovo, Luca Maggio, et al.
Cardiovascular Research|January 22, 2013
Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of CardiologyDerek J Hausenloy, Hans Erik Bøtker, Gianluigi Condorelli, et al.
International Journal of Cardiology|May 15, 2015
Cardioprotection by gene therapy: A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of CardiologyRosalinda Madonna, Christian Cadeddu, Martino Deidda, et al.
Scientific Reports|May 18, 2018
JDP2 overexpression provokes cardiac dysfunction in miceJacqueline Heger, Julia Bornbaum, Alona Würfel, et al.
Cardiovascular Research|October 26, 2014
ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapiesSandrine Lecour, Hans E Bøtker, Gianluigi Condorelli, et al.
Cardiovascular Research|June 12, 2021
COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the HeartMaurizio Pesce, Piergiuseppe Agostoni, Hans-Erik Bøtker, et al.
Redox Biology|October 15, 2023
Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotectionGerd Heusch, Ioanna Andreadou, Robert Bell, et al.
Basic Research in Cardiology|October 18, 2024
The IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): multicenter pig study on the effect of ischemic preconditioningPetra Kleinbongard, Carlos Galán Arriola, Lina Badimon, et al.
Cardiovascular Research|January 19, 2019
ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failureRosalinda Madonna, Linda W Van Laake, Hans Erik Botker, et al.
Cardiovascular Research|September 10, 2021
Circadian rhythms in ischaemic heart disease: key aspects for preclinical and translational research: position paper of the ESC working group on cellular biology of the heartSandrine Lecour, Bastiaan C Du Pré, Hans Erik Bøtker, et al.
Pageof 7